Clinical Report: Aging Condition with a Novel Presentation
Overview
An 81-year-old man with high-grade urothelial carcinoma presented with malaise, weakness, and fever after receiving immune checkpoint inhibitors. Evaluation revealed possible infectious, autoimmune, or malignancy-related causes for his symptoms.
Background
The presentation of fever and malaise in elderly patients with a history of cancer raises concerns for serious underlying conditions, including infections and malignancies. The use of immune checkpoint inhibitors can complicate the clinical picture.
Data Highlights
No significant numerical data or trial results were provided in the source material.
Key Findings
The patient had a history of high-grade urothelial carcinoma and was receiving atezolizumab and tiragolumab.
Symptoms included malaise, generalized weakness, fatigue, and subjective fevers over a period of weeks.
Blood and urine cultures yielded no growth.
CT imaging revealed right-upper-lobe centrilobular nodules and mild pulmonary edema.
Troponin levels were elevated.
Immune-related adverse events from checkpoint inhibitor therapy may contribute to the patient's symptoms.
Clinical Implications
Healthcare providers should consider a broad differential diagnosis in elderly cancer patients presenting with fever and malaise, particularly those on immune checkpoint inhibitors.
Conclusion
This case illustrates the complexity of diagnosing conditions in elderly patients with a cancer history.
